PN

Piyush Naranbhai Paghadal

Active Director Director DIN 11493717
DIN 11493717 First appointment Jan 2026 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2026
Shareholding value - Across - companies

About Piyush Naranbhai Paghadal

Piyush Naranbhai Paghadal has experience in corporate governance. Holds Director role. Currently with 1 company, including Jark Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11493717
Primary Designation Director
First Appointment 20 Jan 2026
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Jark Pharma Private Limited U24231GJ2001PTC039355
Director 20 Jan 2026 Not Provided Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jark Pharma Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Piyush Naranbhai Paghadal

Piyush Naranbhai Paghadal has experience in corporate governance. Holds Director role. Currently with 1 company, including Jark Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Piyush Naranbhai Paghadal is associated with 1 company as Director.

Piyush Naranbhai Paghadal has expertise in General Business.

Piyush Naranbhai Paghadal has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available